Mostrar el registro sencillo del ítem
| dc.contributor.author | Maseda, Emilio | |
| dc.contributor.author | Ramírez, Sofia | |
| dc.contributor.author | Picatto, Pedro | |
| dc.contributor.author | Pelaez-Pelaez, Eva | |
| dc.contributor.author | García-Bernedo, Carlos | |
| dc.contributor.author | Ojeda-Betancur, Nazario | |
| dc.contributor.author | Aguilar, Gerardo | |
| dc.contributor.author | Fores, Beatriz | |
| dc.contributor.author | Solera-Marin, Jorge | |
| dc.contributor.author | Aliano-Pina, María | |
| dc.contributor.author | Tamayo, Eduardo | |
| dc.contributor.author | Ramasco, Fernando | |
| dc.contributor.author | García-Álvarez, Raquel | |
| dc.contributor.author | González-Lisorge, Ada | |
| dc.contributor.author | Giménez, Maria-Jose | |
| dc.contributor.author | Suárez-de-la-Rica, Alejandro | |
| dc.date.accessioned | 2026-01-22T07:34:14Z | |
| dc.date.available | 2026-01-22T07:34:14Z | |
| dc.date.issued | 2019-09-26 | |
| dc.identifier.citation | Maseda E, Ramírez S, Picatto P, Peláez-Peláez E, García-Bernedo C, Ojeda-Betancur N, et al. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality. Patman S, editor. PLoS ONE. 26 de septiembre de 2019;14(9):e0223092. | |
| dc.identifier.issn | 1932-6203 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/23879 | |
| dc.description.abstract | The concept of healthcare-associated infections (as opposed to hospital-acquired infections) in intraabdominal infections (IAIs) is scarcely supported by data in the literature. The aim of the present study was to analyse community-onset IAIs (non-postoperative/non-nosocomial) in patients admitted to intensive care units (ICUs), to investigate differences in resistance patterns linked to healthcare exposure and mortality-associated factors. A one-year prospective observational study (17 Spanish ICUs) was performed distributing cases as healthcare-associated infections (HCAI), community-acquired infections (CAI) and immunocompromised patients (ICP). Bacteria producing extended-spectrum ?-lactamases (ESBL) and/or carbapenemase (CPE), high-level aminoglycoside- and/or methicillin- and/or vancomycin- resistance were considered antimicrobial resistant (AMR). Mortality-associated factors were identified by regression multivariate analysis. Of 345 patients included (18.8% HCAI, 6.1% ICP, 75.1% CAI), 51.6% presented generalized peritonitis; 32.5% were >75 years (55.4% among HCAI). Overall, 11.0% cases presented AMR (7.0% ESBL- and/or CPE), being significantly higher in HCAI (35.4%) vs. CAI (5.8%) (p<0.001) vs. ICP (0%) (p = 0.003). Overall 30-day mortality was 14.5%: 23.1% for HCAI and 11.6% for CAI (p = 0.016). Mortality (R2 = 0.262, p = 0.021) was positively associated with age >75 years (OR = 6.67, 95%CI = 2.56-17.36,p<0.001), Candida isolation (OR = 3.05, 95%CI = 1.18-7.87,p = 0.022), and SAPS II (per-point, OR = 1.08, 95%CI = 1.05-1.11, p<0.001) and negatively with biliary infections (OR = 0.06, 95%CI = 0.01-0.48,p = 0.008). In this study, the antimicrobial susceptibility pattern of bacteria isolated from patients with healthcare contact was shifted to resistance, suggesting the need for consideration of the healthcare category (not including hospital-acquired infections) for severe IAIs. 30-day mortality was positively related with age >75 years, severity and Candida isolation but not with AMR. | |
| dc.language.iso | eng | |
| dc.publisher | PUBLIC LIBRARY SCIENCE | |
| dc.rights | Atribución/Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es | * |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Age Factors | |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Aged, 80 and over | |
| dc.subject.mesh | Anti-Bacterial Agents/pharmacology/therapeutic use | |
| dc.subject.mesh | Bacteria/drug effects/isolation & purification | |
| dc.subject.mesh | Community-Acquired Infections/diagnosis/drug therapy/microbiology/mortality | |
| dc.subject.mesh | Critical Illness/mortality/therapy | |
| dc.subject.mesh | Cross Infection/diagnosis/drug therapy/microbiology/mortality | |
| dc.subject.mesh | Drug Resistance, Bacterial | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Intensive Care Units/statistics & numerical data | |
| dc.subject.mesh | Intraabdominal Infections/diagnosis/drug therapy/microbiology/mortality | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Prospective Studies | |
| dc.subject.mesh | Risk Factors | |
| dc.subject.mesh | Severity of Illness Index | |
| dc.subject.mesh | Spain/epidemiology | |
| dc.title | Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 31557256 | |
| dc.relation.publisherversion | https://dx.plos.org/10.1371/journal.pone.0223092 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1371/journal.pone.0223092 | |
| dc.journal.title | Plos One |